GPR19 and obesity due to melanocortin 4 receptor deficiency: In summary, our study provides robust evidence that GPR19 is a potential regulator of metabolic homeostasis in diet-induced obesity, and thus highlights this GPCR as a possible target for therapeutic applications in the progression of metabolic-associated diseases.